celecoxib has been researched along with Brucellosis in 2 studies
Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty outpatients with depression due to brucellosis with a Hamilton Depression Rating Scale score (HDRS) <19 participated in a randomized, double-blind, placebo-controlled trial and underwent 8 weeks of treatment with either celecoxib (200 mg bid) or placebo as an adjunctive to antibiotic therapy." | 9.20 | Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial. ( Akhondzadeh, S; Ashrafizadeh, SG; Entezari, P; Jafari, S; Rasoulinejad, M; Seddighi, S; Zeinoddini, A, 2015) |
| "Forty outpatients with depression due to brucellosis with a Hamilton Depression Rating Scale score (HDRS) <19 participated in a randomized, double-blind, placebo-controlled trial and underwent 8 weeks of treatment with either celecoxib (200 mg bid) or placebo as an adjunctive to antibiotic therapy." | 5.20 | Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial. ( Akhondzadeh, S; Ashrafizadeh, SG; Entezari, P; Jafari, S; Rasoulinejad, M; Seddighi, S; Zeinoddini, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, P | 1 |
| Turtaut, F | 1 |
| Ouahrani-Bettache, S | 1 |
| Montero, JL | 1 |
| Nishimori, I | 1 |
| Minakuchi, T | 1 |
| Vullo, D | 1 |
| Scozzafava, A | 1 |
| Köhler, S | 1 |
| Winum, JY | 1 |
| Supuran, CT | 1 |
| Jafari, S | 1 |
| Ashrafizadeh, SG | 1 |
| Zeinoddini, A | 1 |
| Rasoulinejad, M | 1 |
| Entezari, P | 1 |
| Seddighi, S | 1 |
| Akhondzadeh, S | 1 |
1 trial available for celecoxib and Brucellosis
| Article | Year |
|---|---|
Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial.
Topics: Adult; Anti-Bacterial Agents; Antidepressive Agents; Brucellosis; Celecoxib; Cyclooxygenase 2 Inhibi | 2015 |
1 other study available for celecoxib and Brucellosis
| Article | Year |
|---|---|
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Clonin | 2010 |